The name is the button.

An agent writes the code now, and a human thumb hovers over Accept all a hundred times a day. The honest question of this decade is what, exactly, you just accepted. So I read the diff.

Eight years as a backend engineer in Stockholm, back in Tokyo since 2023, and I still ship something small most nights, usually badly. My one rule: the only real review of a model is the thing you built with it. That is why there is no leaderboard on this site.

Around a hundred and forty sources come through — the labs' own posts, the papers, the tools, the runtimes and languages nobody is watching yet, the chip under the demo, and the newsletters people actually forward. What is moving gets counted so the week reads at a glance, and every few days I explain one mechanism in plain words.

A story here is a headline, a short excerpt, one image and the link to whoever wrote it. We never reproduce the post; the images belong to their authors. A post written in Japanese appears in Japanese, exactly as it was published, and the link goes to the original.

— Yuki Halvorsen, Tokyo

← Accept All Archive

Tech in AsiaAsia

Indian healthtech startup CureBay raises $10.6m

10.22

The round includes 690 million rupees (US$7.29 million) in equity from IvyCap Ventures and existing investors.

Funding & deals

Read at Tech in Asia ↗

One letter a week, starting soon.

Latest

Indian healthtech startup CureBay raises $10.6m

Related

AsiaDeepSeek raises $15b from Tencent, CATL ahead of IPO Tech in Asia

AsiaIsraeli VC firm Vintage raises $920m in new capital Tech in Asia

AsiaGM leads $108m funding round for battery startup Peak Energy Tech in Asia

EuropeYann LeCun and Arthur Mensch back Zurich robotics startup in $30m pre-seed Sifted

ValleyCode testing startup Blacksmith becomes a unicorn after raising $66M in Series C funding SiliconANGLE

ValleyMeta hit with $25 billion fine for deceiving users on privacy SiliconANGLE